Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA’s 26 NEW MOLECULAR ENTITY APPROVALS IN 1992 ARE FEWER THAN RECORD 30 NME CLEARANCES IN 1991 BUT ARE IMPROVEMENT OVER AGENCY PERFORMANCE FROM 1986-1990
Jan 11 1993
•
By
The Pink Sheet
More from Archive
More from Pink Sheet